Gene expression profiling in early breast cancer treated with neoadjuvant ribociclib plus letrozole (R+L) versus chemotherapy (CT): A correlative analysis of the SOLTI-1402/CORALLEEN phase II trial
L. Manso1, P. Villagrasa2, N. Chic3, J.M. Cejalvo4, Y. Izarzugaza5, B. Cantos6, S. Blanch7, M. Juan8, B. González-Farré9, R. Laeufle10, G. Nuovo11, G. Wilkinson12, M. Coffey13, A. González8, D. Martínez14, L. Paré2, F. Salvador15, X. González-Farré16, A. Prat17, J. Gavila Gregori18
Communication in congress
Results poster
ESMO BREAST
2020
